NINJ1 and cancer: The impact of this adhesion activity on endothelial cells is probably related to the monocyte-mediated inflammatory action reported for the pathogenic role in inflammatory diseases such as sepsis [34], and for the regulatory role of Ninj1 in angiogenesis [35], suggesting that this protein is a promising therapeutic target in cancer.